• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Topics Engaged In

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Oct 13
8:00 am - 9:00 am EDT

Member Forum: Technology Solutions for PALS

Oct 13
6:00 pm - 7:00 pm EDT

Member Forum: Technology Solutions for PALS

Oct 15
9:00 am - 10:00 am EDT

Webinar: The Use of AI in ALS/MND

Oct 17
2:00 pm - 3:00 pm EDT

ALS Association Webinar: So, What’s Next? Understanding the Decisions along an ALS Journey

Oct 21
7:00 am - 8:30 am EDT

Member Roundtable: Defining Rights in the Genetics Era of ALS/MND

View Calendar

  • Michael Lee, Australia

    Michael Lee, Australia

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Anita Forte, USA

    Anita Forte, USA

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Anna Barrow, UK

    Anna Barrow, UK

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Mike Small, UK

    Mike Small, UK

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Alex, Argentina

    Alex, Argentina

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Zabun Nassar, England

    Zabun Nassar, England

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Liam Dwyer, England

    Liam Dwyer, England

  • Rob Tison, USA

    Rob Tison, USA

  • Daniel Hare, USA

    Daniel Hare, USA

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Willi Klein, UK

    Willi Klein, UK

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Greg Heydet, USA

    Greg Heydet, USA

  • John Dinon, Australia

    John Dinon, Australia

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login